parkinson glutathione oxidative ipsc crispr Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease CRISPR-Cas9-Based Technology and Its Relevance
CRISPR Cas9 Based Technology and Its Relevance to Gene Editing in Parkinson's Disease PMC CRISPR Cas9 assisted stem cell therapy in Parkinson's disease Biomaterials Research Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration npj Parkinson's Disease CRISPR And iPSC Disease Modeling And Drug Screening Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 PMC
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




